1 May 2017 - A cystic fibrosis "miracle" drug that would normally cost patients $300,000 a year and a breakthrough rare cancer treatment will become affordable under new Turnbull government subsidies.

Health Minister Greg Hunt says the medicines - among $310 million worth of drugs to be added to the Pharmaceutical Benefits Scheme on Monday - will change and save lives.

Kalydeco will for the first time become available to children with cystic fibrosis aged two to five. Children born in Australia with cystic fibrosis today have a life expectancy of just 37 years but the new wonder drug could extend that by as much as two decades.

It has been listed on the PBS since December 2014 but until now has been restricted to patients aged six or over.

Read Sydney Morning Herald article